Search results for "SC"

Celltrion Files Phase 4 IND with FDA to Support 240 mg High-Dose Zymfentra Regimen in US

Celltrion Files Phase 4 IND with FDA to Support 240 mg High-Dose Zymfentra Regimen in US

Celltrion has submitted an Investigational New Drug application to the U.S. Food and Drug Administration for a Phase 4 clinical trial of Zymfentra...
How to Keep Bananas Fresh Longer: When to Refrigerate, Wrap, and Freeze

How to Keep Bananas Fresh Longer: When to Refrigerate, Wrap, and Freeze

You bring home bright yellow bananas, only to watch dark spots spread within a day or two as the flesh softens.
“One Eye Sees Fine, so It Goes Unnoticed”: How Anisometropia Endangers Children's Vision

“One Eye Sees Fine, so It Goes Unnoticed”: How Anisometropia Endangers Children's Vision

Even when two eyes do not see equally well, many people navigate daily life without obvious trouble as long as one eye...
Compound in Blueberries and Grapes May Prevent Muscle Fat Buildup

Compound in Blueberries and Grapes May Prevent Muscle Fat Buildup

Blueberries and grapes have long been recognized for their health benefits, with blueberries serving as a staple in...
Beyond Survival Rates: Samsung Medical Center Tracks Patient Quality of Life in Value-Based Care

Beyond Survival Rates: Samsung Medical Center Tracks Patient Quality of Life in Value-Based Care

Even when follow-up imaging confirms a patient’s cancer is well controlled with no signs of recurrence, clinical...
Can SVF Injections Delay Knee Replacement? Two-Year Tracking Shows 99% Avoided Surgery

Can SVF Injections Delay Knee Replacement? Two-Year Tracking Shows 99% Avoided Surgery

As populations age, the treatment paradigm for degenerative knee osteoarthritis is shifting from early artificial joint...
Celltrion Targets 33% Shareholder Payout Ratio, Adds 100 Billion Won Share Buyback

Celltrion Targets 33% Shareholder Payout Ratio, Adds 100 Billion Won Share Buyback

Celltrion announced on Aug. 31 that it will return approximately one-third of its annual consolidated net profit to...
Samsung Biologics to Raise ₩3 Trillion in Rights Offering to Fund ₩2.7 Trillion Acquisition of PolyPeptide Group

Samsung Biologics to Raise ₩3 Trillion in Rights Offering to Fund ₩2.7 Trillion Acquisition of PolyPeptide Group

Samsung Biologics is proceeding with a 3 trillion won ($2.25 billion) rights offering, directing approximately 90% of...
Does Skipping Breakfast Spike Blood Sugar? Why Timing Your Morning Meal Matters

Does Skipping Breakfast Spike Blood Sugar? Why Timing Your Morning Meal Matters

For effective blood sugar management, what you eat is only half the equation—when you eat after waking up matters just...
Considering Rhinoplasty Again? Why Revision Surgery Demands a Tailored Approach

Considering Rhinoplasty Again? Why Revision Surgery Demands a Tailored Approach

While rhinoplasty is often perceived as a straightforward cosmetic procedure, surgeons face immense anatomical...